Literature DB >> 2128479

Glucuronidation of 7-hydroxy-4-methylcoumarin by human liver microsomes. Inhibition by certain drugs.

Y M Irshaid1, K I Gharaybeh, F F Ammari, N M Rawashdeh.   

Abstract

Glucuronidation of 7-hydroxy-4-methylcoumarin (7-OH-4-MC) was comparable in three of the four human liver samples studied. In liver sample IV the glucuronidation rate of 7-OH-4-MC was almost 40% of that in the other samples. That might be due to interindividual variation in the capacity to glucuronidate. Glucuronidation rates were not reduced in the one human liver sample which displayed mild centrilobular cholestasis on histopathology. Furosemide (FR), salicylic acid (SA), lorazepam (Z) and menthol (MT) inhibited the glucuronidation of 7-OH-4-MC to varying degrees (30-90%). Paracetamol (PA) and 5-hydroxytryptamine (HT) were not inhibitors of the glucuronidation of 7-OH-4-MC. These findings suggest the presence of other UDP-glucuronosyltransferase (UDPGT) isozymes in the human liver microsomes which are responsible for the glucuronidation of PA and HT than those which glucuronidate 7-OH-4-MC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128479     DOI: 10.1007/BF03190218

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers.

Authors:  K W Bock; B S Bock-Hennig
Journal:  Biochem Pharmacol       Date:  1987-12-01       Impact factor: 5.858

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.

Authors:  J G Conway; F C Kauffman; T Tsukuda; R G Thurman
Journal:  Mol Pharmacol       Date:  1988-01       Impact factor: 4.436

4.  Development of multiple activities of UDP-glucuronyltransferase in human liver.

Authors:  J E Leakey; R Hume; B Burchell
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

5.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Isolation and purification of two human liver UDP-glucuronosyltransferases.

Authors:  Y M Irshaid; T R Tephly
Journal:  Mol Pharmacol       Date:  1987-01       Impact factor: 4.436

7.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.

Authors:  F Bochner; G G Graham; A Polverino; D M Imhoff; R A Tregenza; P E Rolan; L G Cleland
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines.

Authors:  R V Patwardhan; M C Mitchell; R F Johnson; S Schenker
Journal:  Hepatology       Date:  1983 Mar-Apr       Impact factor: 17.425

10.  Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.

Authors:  D E Smith; E T Lin; L Z Benet
Journal:  Drug Metab Dispos       Date:  1980 Sep-Oct       Impact factor: 3.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.